Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A. W. Dinnessen; Carolien C. H. M. Maas; Sanne H. Tonino; Otto Visser; Eduardus F. M. Posthuma; Nicole M. A. Blijlevens; Marie José Kersten; Pieternella J. Lugtenburg; Avinash G. Dinmohamed

doi:10.1038/s41375-022-01535-y

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Manette A. W. Dinnessen^*
, Carolien C. H. M. Maas
, Sanne H. Tonino
, Otto Visser
, Eduardus F. M. Posthuma
, Nicole M. A. Blijlevens
, Marie José Kersten
, Pieternella J. Lugtenburg
, Avinash G. Dinmohamed

^*Corresponding author for this work

Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO box 19079, 3501 DB Utrecht, the Netherlands
University of Amsterdam
Erasmus MC
Reinier de Graaf Groep
Leiden University Medical Center
Radboud University Medical Center
Erasmus University Rotterdam
Vrije Universiteit Amsterdam
Leiden University
Radboud University Nijmegen
Erasmus MC Cancer Institute
Vrije Universiteit (VU) Amsterdam and VU Medical Center

Research output: Contribution to journal › Article › Academic › peer-review

22 Downloads (Pure)

Original language	English
Pages (from-to)	1416-1420
Number of pages	5
Journal	Leukemia
Volume	36
Issue number	5
Early online date	2022
DOIs	https://doi.org/10.1038/s41375-022-01535-y
Publication status	Published - 1 May 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41375-022-01535-y

Causes-of-death-of-patients-with-follicular-lymphoma-in-the-netherlands-by-stage-and-age-groups.pdfFinal published version, 783 KBLicence: Taverne

Cite this

Dinnessen, M. A. W., Maas, C. C. H. M., Tonino, S. H., Visser, O., Posthuma, E. F. M., Blijlevens, N. M. A., Kersten, M. J., Lugtenburg, P. J., & Dinmohamed, A. G. (2022). Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era. Leukemia, 36(5), 1416-1420. https://doi.org/10.1038/s41375-022-01535-y

@article{177bfa8161c5412cb8b9f3cfac662378,

title = "Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era",

author = "Dinnessen, \{Manette A. W.\} and Maas, \{Carolien C. H. M.\} and Tonino, \{Sanne H.\} and Otto Visser and Posthuma, \{Eduardus F. M.\} and Blijlevens, \{Nicole M. A.\} and Kersten, \{Marie Jos{\'e}\} and Lugtenburg, \{Pieternella J.\} and Dinmohamed, \{Avinash G.\}",

note = "Funding Information: We would like to thank the registration clerks of the Netherlands Cancer Registry (NCR) for their dedicated data collection. The nationwide population-based NCR is maintained and hosted by the Netherlands Comprehensive Cancer Organisation (IKNL). The results presented in this paper are based on calculations by IKNL using non-public microdata from Statistics Netherlands. Under certain conditions, these microdata are accessible for statistical and scientific research. For further information: [email protected]. Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest.",

year = "2022",

month = may,

day = "1",

doi = "10.1038/s41375-022-01535-y",

language = "English",

volume = "36",

pages = "1416--1420",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

Dinnessen, MAW, Maas, CCHM, Tonino, SH, Visser, O, Posthuma, EFM, Blijlevens, NMA, Kersten, MJ, Lugtenburg, PJ & Dinmohamed, AG 2022, 'Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era', Leukemia, vol. 36, no. 5, pp. 1416-1420. https://doi.org/10.1038/s41375-022-01535-y

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era. / Dinnessen, Manette A. W.; Maas, Carolien C. H. M.; Tonino, Sanne H. et al.
In: Leukemia, Vol. 36, No. 5, 01.05.2022, p. 1416-1420.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups

T2 - a population-based study in the pre- and post-rituximab era

AU - Dinnessen, Manette A. W.

AU - Maas, Carolien C. H. M.

AU - Tonino, Sanne H.

AU - Visser, Otto

AU - Posthuma, Eduardus F. M.

AU - Blijlevens, Nicole M. A.

AU - Kersten, Marie José

AU - Lugtenburg, Pieternella J.

AU - Dinmohamed, Avinash G.

N1 - Funding Information: We would like to thank the registration clerks of the Netherlands Cancer Registry (NCR) for their dedicated data collection. The nationwide population-based NCR is maintained and hosted by the Netherlands Comprehensive Cancer Organisation (IKNL). The results presented in this paper are based on calculations by IKNL using non-public microdata from Statistics Netherlands. Under certain conditions, these microdata are accessible for statistical and scientific research. For further information: [email protected]. Funding Information: MJK: research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene. SHT: honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead. PJL: research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene. The other authors have no conflict of interest.

PY - 2022/5/1

Y1 - 2022/5/1

UR - https://www.scopus.com/pages/publications/85125675692

U2 - 10.1038/s41375-022-01535-y

DO - 10.1038/s41375-022-01535-y

M3 - Article

C2 - 35246605

SN - 0887-6924

VL - 36

SP - 1416

EP - 1420

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

UN SDGs

Access to Document

Other files and links

Cite this